Merck (MRK) – Merck is buying privately held drugmaker VelosBio for $2.75 billion in cash, in a move designed to boost its oncology treatment pipeline.
Brief: Merck is buying drug maker VelosBio for $2.75 billion in cash
Merck (MRK) – Merck is buying privately held drugmaker VelosBio for $2.75 billion in cash, in a move designed to boost its oncology treatment pipeline.
